Looks like there`s been an error while trying to load this page.
Our team has been notified but please contact us using the email support widget if the problem persists.
| Metrics | Range | Conclusion |
|---|---|---|
| Selected LTM EBIT Multiple | 29.4x - 32.5x | 30.9x |
| Selected Fwd EBIT Multiple | 33.4x - 36.9x | 35.1x |
| Fair Value | A$0.79 - A$1.06 | A$0.93 |
| Upside | -43.4% - -24.2% | -33.8% |
| Benchmarks | Ticker | Full Ticker |
| Sonic Healthcare Limited | SHL | ASX:SHL |
| Australian Clinical Labs Limited | ACL | ASX:ACL |
| Ramsay Health Care Limited | RHC | ASX:RHC |
| Freedom Care Group Holdings Limited | FCG | ASX:FCG |
| Rhythm Biosciences Limited | RHY | ASX:RHY |
| Healius Limited | HLS | ASX:HLS |
| - | - | - |
| Select LTM EBIT Multiple | |||||||
| Benchmark Companies | |||||||
| SHL | ACL | RHC | FCG | RHY | HLS | ||
| ASX:SHL | ASX:ACL | ASX:RHC | ASX:FCG | ASX:RHY | ASX:HLS | ||
| Historical EBIT Growth | |||||||
| 5Y CAGR | 2.7% | NM- | -2.2% | NM- | NM- | -9.5% | |
| 3Y CAGR | -23.4% | -21.2% | 10.8% | NM- | NM- | -37.7% | |
| Latest Twelve Months | 16.1% | 23.3% | 12.4% | -64.6% | 75.8% | 31.3% | |
| Historical EBIT Profit Margin | |||||||
| 5 Year Average Margin | 15.8% | 14.9% | 4.8% | 10.3% | -575.3% | 10.1% | |
| Prior Fiscal Year | 12.5% | 9.4% | 4.4% | 16.4% | -272.6% | 5.7% | |
| Latest Fiscal Year | 9.6% | 9.0% | 5.6% | 4.2% | -408.6% | 3.8% | |
| Latest Twelve Months | 10.0% | 9.1% | 5.6% | 4.2% | -67.0% | 3.6% | |
| Current Trading Multiples | |||||||
| EV / LTM Revenue | 1.73x | 1.21x | 1.12x | 0.08x | 5.63x | 1.29x | |
| EV / LTM EBITDA | 12.8x | 11.0x | 12.6x | 1.5x | -8.8x | 24.3x | |
| EV / LTM EBIT | 17.2x | 13.2x | 20.1x | 2.0x | -8.4x | 35.3x | |
| Low | Mid | High | |||||
| Benchmark EV / LTM EBIT | -8.4x | 13.2x | 20.1x | ||||
| Historical EV / LTM EBIT | 18.3x | 18.3x | 18.3x | ||||
| Selected EV / LTM EBIT | 29.4x | 30.9x | 32.5x | ||||
| (x) LTM EBIT | 65 | 65 | 65 | ||||
| (=) Implied Enterprise Value | 1,912 | 2,012 | 2,113 | ||||
| (-) Non-shareholder Claims * | (1,283) | (1,283) | (1,283) | ||||
| (=) Equity Value | 628 | 729 | 830 | ||||
| (/) Shares Outstanding | 726.1 | 726.1 | 726.1 | ||||
| Implied Value Range | 0.87 | 1.00 | 1.14 | ||||
| FX Rate: AUD/AUD | 1.0 | 1.0 | 1.0 | Market Price | |||
| Implied Value Range (Trading Cur) | 0.87 | 1.00 | 1.14 | 1.40 | |||
| Upside / (Downside) | -38.2% | -28.3% | -18.4% | ||||
| Equity Waterfall | |||||||
| Benchmark Companies | |||||||
| (in millions) | SHL | ACL | RHC | FCG | RHY | HLS | |
| Enterprise Value | 16,101 | 880 | 19,162 | 4 | 18 | 2,300 | |
| (+) Cash & Short Term Investments | 541 | 22 | 343 | 0 | 4 | 115 | |
| (+) Investments & Other | 206 | 0 | 12 | 0 | 0 | 0 | |
| (-) Debt | (4,798) | (315) | (11,284) | 0 | (0) | (1,399) | |
| (-) Other Liabilities | (141) | (0) | (623) | 0 | 0 | 0 | |
| (-) Preferred Stock | 0 | 0 | (252) | 0 | 0 | 0 | |
| (-) Other | 0 | 0 | 0 | 0 | 0 | 0 | |
| Value of Common Equity | 11,909 | 585 | 7,357 | 4 | 22 | 1,017 | |
| (/) Shares Outstanding | 480.2 | 197.1 | 229.3 | 108.3 | 283.6 | 726.1 | |
| Implied Stock Price | 24.80 | 2.97 | 32.09 | 0.04 | 0.08 | 1.40 | |
| FX Conversion Rate to Trading Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |
| Implied Stock Price (Trading Cur) | 24.80 | 2.97 | 32.09 | 0.04 | 0.08 | 1.40 | |
| Trading Currency | AUD | AUD | AUD | AUD | AUD | AUD | |
| FX Rate to Reporting Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |